TSX-V:VPT - TSX Venture Exchange - CA92281P2008 - Common Stock - Currency: CAD
TSX-V:VPT (6/27/2025, 7:00:00 PM)
0.135
+0.01 (+3.85%)
The current stock price of VPT.CA is 0.135 CAD. In the past month the price increased by 35%. In the past year, price decreased by -37.21%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRN.CA | PROFOUND MEDICAL CORP | N/A | 242.20M | ||
MIR.CA | MEDMIRA INC | N/A | 60.66M | ||
TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 44.60M | ||
NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 28.30M | ||
ASG.CA | AURORA SPINE CORP | N/A | 24.71M | ||
MDX.CA | MEDX HEALTH CORP | N/A | 24.29M | ||
PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 23.38M | ||
CNVI.CA | CONAVI MEDICAL CORP | N/A | 16.82M | ||
THRM.CA | THERMA BRIGHT INC | N/A | 4.54M | ||
VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 439.40K |
VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company is headquartered in Toronto, Ontario. The company went IPO on 2005-11-09. The company is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. The company develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. The company provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. The company has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
VENTRIPOINT DIAGNOSTICS LTD
18 Hook Ave, Unit 101
TORONTO ONTARIO M2N 5Y7 CA
CEO: George Adams
Employees: 0
Phone: 14168484156
The current stock price of VPT.CA is 0.135 CAD. The price increased by 3.85% in the last trading session.
The exchange symbol of VENTRIPOINT DIAGNOSTICS LTD is VPT and it is listed on the TSX Venture Exchange exchange.
VPT.CA stock is listed on the TSX Venture Exchange exchange.
VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) has a market capitalization of 22.03M CAD. This makes VPT.CA a Nano Cap stock.
VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) currently has 0 employees.
VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) has a support level at 0.13 and a resistance level at 0.15. Check the full technical report for a detailed analysis of VPT.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
VPT.CA does not pay a dividend.
VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) will report earnings on 2025-08-27.
VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
ChartMill assigns a technical rating of 5 / 10 to VPT.CA. When comparing the yearly performance of all stocks, VPT.CA is a bad performer in the overall market: 91.53% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to VPT.CA. Both the profitability and financial health of VPT.CA have multiple concerns.
Over the last trailing twelve months VPT.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 2.33% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -529.04% | ||
ROE | N/A | ||
Debt/Equity | N/A |